News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,594 Results
Type
Article (1103)
Company Profile (3)
Press Release (37488)
Section
Business (14151)
Career Advice (13)
Deals (2939)
Drug Delivery (2)
Drug Development (3207)
Employer Resources (3)
FDA (564)
Job Trends (639)
News (18519)
Policy (1521)
Tag
2027 Pharm Country Standard (1)
Academia (62)
Accelerated approval (2)
Allergies (1)
Alliances (2659)
ALS (9)
Alzheimer's disease (111)
Antibody-drug conjugate (ADC) (13)
Approvals (588)
Artificial intelligence (45)
ASCO (9)
Autoimmune disease (12)
Automation (1)
Bankruptcy (22)
Best Places to Work (376)
BIO (6)
Biosimilars (4)
BioSpace Insights (1)
Biotechnology (16)
Bladder cancer (7)
Brain cancer (3)
Breast cancer (74)
Cancer (278)
Cardiovascular disease (10)
Career advice (13)
CAR-T (1)
CDC (1)
Cell therapy (26)
Clinical research (2714)
Collaboration (103)
Compensation (11)
Complete response letters (1)
COVID-19 (229)
CRISPR (1)
C-suite (67)
Cystic fibrosis (3)
Data (271)
Depression (7)
Dermatology (1)
Diabetes (11)
Diagnostics (497)
Digital health (3)
Diversity, equity & inclusion (2)
Drug discovery (29)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (4642)
Employer resources (3)
Events (5024)
Executive appointments (68)
FDA (691)
Funding (107)
Gene editing (3)
Generative AI (1)
Gene therapy (3)
GLP-1 (25)
Government (121)
Guidances (13)
Healthcare (1001)
Hematology (1)
HIV (1)
Huntington's disease (1)
IgA nephropathy (2)
Immunology and inflammation (2)
Immuno-oncology (3)
Indications (2)
Infectious disease (238)
Inflammatory bowel disease (4)
Intellectual property (9)
Interviews (3)
IPO (1175)
Job creations (270)
Job search strategy (10)
Layoffs (12)
Legal (608)
Liver cancer (1)
Longevity (2)
Lung cancer (20)
Lymphoma (3)
Machine learning (4)
Management (1)
Manufacturing (35)
Medical device (761)
Medtech (771)
Mergers & acquisitions (1875)
Metabolic disorders (16)
mRNA (4)
Multiple sclerosis (2)
Neurodegenerative disease (14)
Neuropsychiatric disorders (2)
Neuroscience (158)
NextGen: Class of 2026 (269)
Non-profit (94)
Obesity (5)
Opinion (2)
Ovarian cancer (3)
Pain (11)
Pancreatic cancer (23)
Parkinson's disease (9)
Partnered (12)
Patents (29)
Patient recruitment (23)
People (4290)
Pharmaceutical (4)
Phase 1 (830)
Phase 2 (1374)
Phase 3 (796)
Pipeline (322)
Postmarket research (68)
Preclinical (365)
Press Release (2)
Prostate cancer (20)
Psychedelics (2)
Radiopharmaceuticals (25)
Rare diseases (42)
Real estate (279)
Recruiting (1)
Regulatory (976)
Reports (13)
Research institute (71)
Rett syndrome (3)
RNA editing (3)
Schizophrenia (5)
Series A (8)
Series B (4)
Service/supplier (2)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (197)
State (1)
Supply chain (3)
Vaccines (29)
Venture capital (1)
Weight loss (2)
Women's health (3)
Date
Today (4)
Last 7 days (27)
Last 30 days (122)
Last 365 days (1589)
2026 (975)
2025 (1655)
2024 (1930)
2023 (2200)
2022 (2968)
2021 (3674)
2020 (2882)
2019 (1946)
2018 (1551)
2017 (1458)
2016 (1380)
2015 (1746)
2014 (1453)
2013 (1211)
2012 (1341)
2011 (1321)
2010 (1444)
Location
Africa (38)
Alabama (2)
Arizona (13)
Asia (1458)
Australia (128)
California (377)
Canada (1170)
China (10)
Colorado (18)
Connecticut (7)
Delaware (10)
Europe (2737)
Florida (92)
Georgia (9)
Idaho (3)
Illinois (40)
India (6)
Indiana (52)
Japan (29)
Kansas (3)
Kentucky (2)
Louisiana (2)
Maryland (24)
Massachusetts (237)
Michigan (53)
Minnesota (72)
Montana (9)
Nebraska (3)
Nevada (10)
New Hampshire (11)
New Jersey (274)
New Mexico (6)
New York (203)
North Carolina (79)
North Dakota (1)
Northern California (184)
Ohio (15)
Oklahoma (4)
Oregon (1)
Pennsylvania (203)
Puerto Rico (1)
South America (51)
South Carolina (1)
Southern California (120)
Tennessee (12)
Texas (208)
United States (2051)
Utah (5)
Virginia (8)
Washington D.C. (1)
Washington State (20)
Wisconsin (39)
Wyoming (2)
38,594 Results for "oncocyte corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sharp Therapeutics Corp. Announces Results from Annual Meeting of Shareholders
July 21, 2026
·
3 min read
Press Releases
Phlow Corp. Appoints Sripathy Venkatraman, Ph.D, As Chief Scientific Officer
July 22, 2026
·
3 min read
Press Releases
MustGrow Biologics Corp. Announces Results of Shareholder Meeting
June 26, 2026
·
4 min read
Press Releases
OrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026
July 22, 2026
·
1 min read
Press Releases
OrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial Guidance
August 4, 2026
·
18 min read
Business
Oncocyte Reports First Quarter 2024 Financial Results
Oncocyte Corporation, a precision diagnostics company, reported financial results for the quarter ended March 31, 2024.
May 15, 2024
·
12 min read
Business
Oncocyte Appoints Andrea James as Chief Financial Officer
Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer.
June 17, 2024
·
5 min read
Business
Oncocyte to Announce First Quarter 2024 Financial Results
Oncocyte Corporation announced today that the company will release its first quarter 2024 financial results on Wednesday, May 15, 2024, after U.S. market close.
May 13, 2024
·
1 min read
Pharm Country
Breakthrough in Kidney Transplant Monitoring: PRISM MarketView Spotlights Oncocyte’s VitaGraft Study
Oncocyte’s VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine.
June 3, 2024
·
2 min read
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
1 of 3,860
Next
